Successful topical treatment with mitomycin-C in a female with post-brachytherapy vaginal stricture
Pietro Betalli1, Federica De Corti, Daria Minucci
1Pediatric Surgery Unit, Department of Pediatrics, University Hospital, Padova, Italy.
Insights
Topical mitomycin-C offers a novel treatment for pediatric vaginal strictures, a rare condition often linked to congenital issues or cancer therapy. This approach may overcome compliance challenges associated with traditional dilator therapy in children.
Area of Science:
- Pediatric Gynecology
- Oncology
- Surgical Complications
Background:
- Vaginal strictures in children are uncommon, often resulting from congenital abnormalities, surgical interventions, or cancer treatments like brachytherapy.
- Current treatment options, including dilators, face compliance issues in pediatric patients.
- There is no standardized therapy for pediatric vaginal strictures.
Observation:
- This study focuses on a rare case of vaginal stricture in a pediatric patient secondary to brachytherapy.
- The patient underwent treatment involving the topical application of mitomycin-C.
Findings:
- Topical mitomycin-C was utilized as a therapeutic intervention for a pediatric vaginal stricture.
- This case report details the application and potential efficacy of mitomycin-C in this context.
Implications:
- Topical mitomycin-C presents a potential alternative treatment for pediatric vaginal strictures, particularly when conservative methods like dilators are challenging.
- Further research is warranted to establish the safety and efficacy of mitomycin-C for pediatric vaginal strictures.
- This approach could improve treatment outcomes for children suffering from this rare condition.
Abstract:
Vaginal strictures are rare entities in pediatric population, mainly due to congenital genito-urinary tract malformations and sequelae of their surgical treatment, recurrent vaginitis and multisciplinary therapy for malignant tumors. The therapy of choice is not standardized. Conservative treatments are favored and dilators seem to be very effective, but their use in children is difficult due to poor compliance. We report our experience with topical application of mitomycin-C in a female with vaginal stricture secondary to brachytherapy.
